Postexposure Prophylaxis After Sexual Assaults: A Prospective Cohort Study
- 1 April 2005
- journal article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 32 (4) , 214-219
- https://doi.org/10.1097/01.olq.0000149785.48574.3e
Abstract
Objective: The objective of this study was to evaluate HIV postexposure prophylaxis (PEP) protocol in rape victims. Study: The victims were assigned to 1 of 3 categories, according to the severity of exposure (I—low, II—moderate, III—high). HIV PEP was provided to victims in groups II (Zdv + 3TC) and III (Zdv + 3TC + PI) until 72 hours after exposure. The follow-up was 6 months. Results: From May 1997 to October 2001, 347 victims were attended. PEP was offered to 278 victims (141 in group II and 137 in group III). Side effects were more common in group III (P <0.01). No seroconversion was diagnosed in the 180 victims that completed the follow-up. Univariate analysis showed that the schooling level, knowledge of the aggressor's HIV status, and the use of PEP were associated with compliance. Conclusions: Triple therapy was associated with side effects, which suggested that drug regimes should be reviewed. The variables related to a high risk of HIV transmission were also significant for compliance.Keywords
This publication has 23 references indexed in Scilit:
- Post-exposure prophylaxis after non-occupational HIV exposure: impact of recommendations on physicians’ experiences and attitudesAIDS, 2002
- Post-exposure prophylaxis for HIV infection after sexual assault: When is it indicated?Emergency Medicine Journal, 2001
- Feasibility of Postexposure Prophylaxis (PEP) against Human Immunodeficiency Virus Infection after Sexual or Injection Drug Use Exposure: The San Francisco PEP StudyThe Journal of Infectious Diseases, 2001
- From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infectionSexually Transmitted Infections, 1999
- The Care of Persons with Recent Sexual Exposure to HIVAnnals of Internal Medicine, 1998
- A Case–Control Study of HIV Seroconversion in Health Care Workers after Percutaneous ExposureNew England Journal of Medicine, 1997
- Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study.American Journal of Epidemiology, 1997
- Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to InfantNew England Journal of Medicine, 1996
- Prevention of SIV Infection in Macaques by ( R )-9-(2-Phosphonylmethoxypropyl)adenineScience, 1995
- The Efficiency of Male-to Female and Female-to-Male Sexual Transmission of the Human Immunodeficiency VirusEpidemiology, 1994